Bone marrow derived stem cells (BMSC) may improve memory in Alzheimer’s Disease

Abstract Background A 73‐year‐old female with a 3 year history of Alzheimer’s disease was treated within the protocol of The Alzheimer’s Autism and Cognitive Impairment Stem Cell Treatment Study (ACIST), an IRB approved clinical study registered with clinicaltrials.gov NCT 03724136. Method The procedure consists of bone marrow aspiration, cell separation using an FDA cleared class 2 device, and intravenous and intranasal administration of the stem cell fraction. The patient’s son, a physician, recorded a video on the day prior to surgery, and on the first postoperative day. Result 1 Day Pre‐Surgery https://drive.google.com/file/d/1fTfceevWLpPSh4J4V6XGenx3bMwNzEBp/view?usp=drive_web 1 Day Post‐Surgery https://drive.google.com/file/d/14AhVTes2kQ50tWzj6eWE5fEamgEJWa_D/view?usp=drive_web The improvements lasted several weeks before gradually regressing. Conclusion Potential mechanisms of action of bone marrow derived stem cells (BMSC) are varied. These may include: the release of neurotrophic factors (NTF) including ciliary neurotrophic factor which has been shown to alleviate excitotoxicity in neurons; the release NGF (nerve growth factor) which enhances neuronal survival and function; and, immune modulation in a setting where neuroinflammation may exacerbate damage. BMSC can transfer their own organelles, including mitochondria and lysosomes, to injured or stressed cells, as well as release exosomes (secretome) containing proteins, mRNA and miRNA, which have the ability to regenerate axons and address neuronal dysfunction. Human mesenchymal cells (hMSC), a subpopulation of BMSC, have been reported to provide de novo neuron regeneration. BMSC, through fusion with Muller cells (a retinal specific glial cell) can lead to new ganglion cells. Potentially, there may be local activity of BMSC directly in the hippocampus to help clear exogenous amyloid deposits, reduce microglial immunologic activity and enhance axonal recovery, including dendritic recovery and activity. The improvement of long‐term memory in this patient suggests that neuron connectivity remains in place, for long periods after diagnosis, and can potentially be recovered. Future research should include isolating components responsible for the improvement with the hope of extending the duration of response.

Authors

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.083902
Citations
1
Primary Topic
Mesenchymal stem cell research
Type
article
Field-Weighted Citation Impact
0.44
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bone marrow derived stem cells (BMSC) may improve memory in Alzheimer’s Disease

Steven Levy, Jeffrey Weiss
1 citations
Alzheimer s & Dementia
Mesenchymal stem cell research
0.44
article

Bone marrow derived stem cells (BMSC) may improve memory in Alzheimer’s Disease

Steven Levy, Jeffrey Weiss
article en
1 citations

Abstract

Abstract Background A 73‐year‐old female with a 3 year history of Alzheimer’s disease was treated within the protocol of The Alzheimer’s Autism and Cognitive Impairment Stem Cell Treatment Study (ACIST), an IRB approved clinical study registered with clinicaltrials.gov NCT 03724136. Method The procedure consists of bone marrow aspiration, cell separation using an FDA cleared class 2 device, and intravenous and intranasal administration of the stem cell fraction. The patient’s son, a physician, recorded a video on the day prior to surgery, and on the first postoperative day. Result 1 Day Pre‐Surgery https://drive.google.com/file/d/1fTfceevWLpPSh4J4V6XGenx3bMwNzEBp/view?usp=drive_web 1 Day Post‐Surgery https://drive.google.com/file/d/14AhVTes2kQ50tWzj6eWE5fEamgEJWa_D/view?usp=drive_web The improvements lasted several weeks before gradually regressing. Conclusion Potential mechanisms of action of bone marrow derived stem cells (BMSC) are varied. These may include: the release of neurotrophic factors (NTF) including ciliary neurotrophic factor which has been shown to alleviate excitotoxicity in neurons; the release NGF (nerve growth factor) which enhances neuronal survival and function; and, immune modulation in a setting where neuroinflammation may exacerbate damage. BMSC can transfer their own organelles, including mitochondria and lysosomes, to injured or stressed cells, as well as release exosomes (secretome) containing proteins, mRNA and miRNA, which have the ability to regenerate axons and address neuronal dysfunction. Human mesenchymal cells (hMSC), a subpopulation of BMSC, have been reported to provide de novo neuron regeneration. BMSC, through fusion with Muller cells (a retinal specific glial cell) can lead to new ganglion cells. Potentially, there may be local activity of BMSC directly in the hippocampus to help clear exogenous amyloid deposits, reduce microglial immunologic activity and enhance axonal recovery, including dendritic recovery and activity. The improvement of long‐term memory in this patient suggests that neuron connectivity remains in place, for long periods after diagnosis, and can potentially be recovered. Future research should include isolating components responsible for the improvement with the hope of extending the duration of response.

Alzheimer s & DementiaVol. 20(S4)
Openalex Percentile: Top 28%
Mesenchymal stem cell research
0.44
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Bone marrow derived stem cells (BMSC) may improve memory in Alzheimer’s Disease — Steven Levy, Jeffrey Weiss · Alzheimer s & Dementia (2024) | TGRS Research Map | TGRS